Literature DB >> 11819858

Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.

W Wang1, S K Qin, B A Chen, H Y Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11819858      PMCID： PMC4695578          DOI： 10.3748/wjg.v7.i5.702

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  19 in total

1.  A study on arsenic trioxide inducing in vitro apoptosis of gastric cancer cell lines.

Authors:  Qin-Long Gu; Ning-Li Li; Zheng-Gang Zhu; Hao-Ran Yin; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.

Authors:  G Q Chen; J Zhu; X G Shi; J H Ni; H J Zhong; G Y Si; X L Jin; W Tang; X S Li; S M Xong; Z X Shen; G L Sun; J Ma; P Zhang; T D Zhang; C Gazin; T Naoe; S J Chen; Z Y Wang; Z Chen
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

3.  Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.

Authors:  P Rousselot; S Labaume; J P Marolleau; J Larghero; M H Noguera; J C Brouet; J P Fermand
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

4.  [Seven years' summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide--an analysis of 242 cases].

Authors:  P Zhang; S Wang; L Hu; F Qiu; H Yang; Y Xiao; X Li; X Han; J Zhou; P Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2000-02

5.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Authors:  G Q Chen; X G Shi; W Tang; S M Xiong; J Zhu; X Cai; Z G Han; J H Ni; G Y Shi; P M Jia; M M Liu; K L He; C Niu; J Ma; P Zhang; T D Zhang; P Paul; T Naoe; K Kitamura; W Miller; S Waxman; Z Y Wang; H de The; S J Chen; Z Chen
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

6.  [Preliminary study on the arsenic trioxide-induced NB4 cell apoptosis and its molecular mechanisms].

Authors:  G Chen; J Zhu; X Shi; H Zhong; W Liu; X Jin; W Tang; X Li; J Ni; S Xiong; Z Shen; J Ma; P Zhang; T Zhang; G Claude; S Chen; L Chen; Z Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  1997-01

7.  [Effects of arsenic trioxide on the subcellular localization of PML/PML-RARalpha protein in leukemic cells].

Authors:  J Ni; G Chen; J Zhu; H Zhong; W Tang; X Li; S Xiong; Z Shen; S Chen; Z Wang; L Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  1997-01

8.  [Regulation of arsenic trioxide-inducing apoptosis].

Authors:  X Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  1999-05

9.  Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

Authors:  S L Soignet; P Maslak; Z G Wang; S Jhanwar; E Calleja; L J Dardashti; D Corso; A DeBlasio; J Gabrilove; D A Scheinberg; P P Pandolfi; R P Warrell
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

10.  [A fungus-derived novel nucleoside transport inhibitor potentiates the activity of antitumor drugs].

Authors:  J Su; Y S Zhen; C Q Qi; W J Chen
Journal:  Yao Xue Xue Bao       Date:  1994
View more
  17 in total

1.  Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.

Authors:  Pei-Chih Lee; Rajesh Kakadiya; Tsann-Long Su; Te-Chang Lee
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Arsenic Trioxide Combined with VCMP or VAD Chemotherapy in Patients with Refractory or Relapsed Multiple Myeloma in a Single Institution of China.

Authors:  Xiaoning Wang; Mei Zhang; Meihua Wang; Pengcheng He; Xin Liu; Limei Chen; Jieying Xi; Mengchang Wang; Jin Li; Huasheng Liu; Haitao Zhang
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-28       Impact factor: 0.900

3.  Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.

Authors:  Clarisse S Muenyi; Allan R Pinhas; Teresa W Fan; Guy N Brock; C William Helm; J Christopher States
Journal:  Toxicol Sci       Date:  2012-02-13       Impact factor: 4.849

4.  Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.

Authors:  Ulana Kotowski; Gregor Heiduschka; Markus Brunner; Boban M Erovic; Helga Martinek; Dietmar Thurnher
Journal:  Oncol Lett       Date:  2012-03-14       Impact factor: 2.967

5.  Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.

Authors:  Xiao-Hong Li; Xiao-Kun Li; Shao-Hui Cai; Fu-Xing Tang; Xue-Yun Zhong; Xian-Da Ren
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

6.  Nitric oxide and calcium ions in apoptotic esophageal carcinoma cells induced by arsenite.

Authors:  Zhong-Ying Shen; Wen-Ying Shen; Ming-Hua Chen; Jian Shen; Wei-Jie Cai; Zeng Yi
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

7.  Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells.

Authors:  Zhengmao Zhang; Zhen Xie; Guangyu Sun; Pingfang Yang; Jia Li; Hongfang Yang; Shuang Xiao; Yang Liu; Hongbing Qiu; Lijun Qin; Chao Zhang; Fenghua Zhang; Baoen Shan
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Serum from rabbit orally administered cobra venom inhibits growth of implanted hepatocellular carcinoma cells in mice.

Authors:  Peng Sun; Xian-Da Ren; Hai-Wei Zhang; Xiao-Hong Li; Shao-Hui Cai; Kai-He Ye; Xiao-Kun Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

9.  Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.

Authors:  H Zhang; X Zhou; C Xu; J Yang; J Xiang; M Tao; Y Xie
Journal:  Cancer Gene Ther       Date:  2015-11-13       Impact factor: 5.987

10.  Synergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.

Authors:  Jian-Wei Liu; Yi Tang; Yan Shen; Xue-Yun Zhong
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.